For Investors
Innovation in cancer diagnostics
18M New cases of cancer worldwide, 2020. +55% increase in Cancer incidence rates projected between 2020-2040 worldwide. More than 4 in 10 of new cancers are lung, breast, bowel or prostate cancer, 2020 worldwide.
The colorectal cancer screening and diagnostics market ($38.5B*) is experiencing significant growth, driven by the increasing global prevalence of colorectal cancer and heightened awareness regarding the benefits of early detection.
* BIS Research Inc.
Results of invitro (IVDs) testing influence as many as 70% of clinical decisions. Allowing earlier and more targeted treatments, IVDs help to reduce hospital stays and convalescences, resulting in healthier populations, reduced costs, and economic growth in the long run.
For further information
Meet the collaborators who make our work possible
“GPs need faster access to smarter tests so that they only need to send people at the highest risk of cancer to hospital.”
Sara Hiom
Former director of Cancer Research UK
